BLOOD SAMPLES WITHOUT CONSENT: Kaplan Hospital Cardiology Chief Faces New Allegations Amid Widening Medical Training Scandal
Kaplan Medical Center in Rechovot is facing another serious controversy involving its cardiology department, with hospital administrators filing a complaint against department director Prof. Kobi George over suspicions that blood was collected from patients for medical research without obtaining their informed consent. The allegations come less than two months after revelations that doctors training in the same department allegedly received specialist qualifications despite failing to complete mandatory portions of their medical training.
The latest allegations have intensified scrutiny of the hospital’s cardiology division, which was already under investigation by Israel’s Health Ministry over irregularities in its residency program. George, who has remained in his position despite the earlier controversy, now faces additional questions concerning the collection and use of patient blood samples for research.
The earlier investigation began after reports surfaced that cardiology residents at Kaplan had been permitted for years to bypass the internal medicine component of their specialist training. The arrangement allegedly operated under George’s direction and supervision, raising serious concerns about whether physicians had received the clinical experience required before being certified as cardiology specialists.
Despite the seriousness of those findings, George continued serving as head of the department while the Health Ministry established an independent investigative panel to examine the circumstances surrounding the training irregularities.
The inquiry initially focused on the responsibilities of Kaplan’s senior management and the health insurance organizations involved in the residency process. Investigators subsequently broadened their examination to include Prof. Zion Hagay, chairman of Kaplan’s residency committee and president of the Israel Medical Association.
Officials connected to the residency program were called in for questioning, including the director of the hospital’s internal medicine department, who reportedly approved training documentation that investigators suspect did not accurately reflect the education the residents had received.
The newly reported allegations involving blood samples raise a separate set of concerns about patient rights and compliance with medical research regulations. According to the suspicions, blood specimens were obtained from patients for research purposes without their knowledge or the informed consent required under established medical ethics procedures.
In Israel, medical studies involving human participants generally require authorization from an institutional Helsinki Committee, which is responsible for reviewing research proposals and ensuring that appropriate ethical safeguards are in place. Such approval does not eliminate the requirement to obtain informed consent from individual participants when consent is legally required.
The distinction is particularly important in cases involving the collection of biological material, since patients must ordinarily be informed about the nature and purpose of research participation before agreeing to provide samples. The allegations against George have raised questions about whether those protections were properly observed in the research activities under examination.
Additional information indicates that the hospital’s response has gone beyond submitting a complaint. George has been suspended from his position as director of cardiology, and the matter has been referred to the Israel Police for investigation.
The complaint was reportedly filed last week after a member of the medical staff approached hospital administrators and requested that the circumstances surrounding the research be examined. Preliminary findings subsequently raised concerns that blood samples had been collected or used for laboratory research without the necessary patient authorization.
The police complaint, originally submitted in Rehovot, has reportedly been transferred to the Central District Police fraud investigation unit. The Health Ministry has also confirmed receiving information from hospital management concerning the allegations and the steps taken in response.
Authorities have not publicly established how many patients may have been affected, how long the suspected practices continued, or the precise circumstances under which the samples were collected. Those questions remain part of the investigation.
The hospital, which operates under Clalit Health Services, has emphasized that the cardiology department continues providing medical treatment despite the suspension of its director. Administrators said measures have been implemented to protect patients and ensure that necessary cardiac services remain available.
The separate residency controversy has also produced consequences for the department. Following the earlier disclosures, the Israel Medical Association reportedly withdrew Kaplan’s authorization to train cardiology residents while George remained part of the department’s medical staff.
The previous allegations centered on documentation indicating that residents had completed required rotations in internal medicine when, according to the reports, those rotations had not actually taken place. The discrepancies raised concerns that physicians had obtained specialist certification without fulfilling all the requirements of their training programs.
Investigators are examining how the records were approved, who was responsible for verifying the training, and whether hospital officials or supervising physicians were aware of the discrepancies.
The Health Ministry and Clalit have both initiated reviews of the residency affair, while the new allegations concerning patient blood samples have brought police investigators into the picture.
The hospital has also established a dedicated service for patients seeking information about the suspected research irregularities.
George has disputed the characterization of the allegations against him. In comments provided through his representatives, he maintained that the matter involved, at most, alleged improper conduct, rather than the more serious wrongdoing suggested by the accusations.
Both controversies remain under investigation, and no final findings establishing criminal wrongdoing have been announced.
{Matzav.com}
